{
    "1613204147683172352": {
        "attachments": {
            "media_keys": [
                "13_1613204092658061315"
            ]
        },
        "author_id": "62465691",
        "created_at": "2023-01-11T16:00:15.000Z",
        "edit_history_tweet_ids": [
            "1613204147683172352"
        ],
        "entities": {
            "annotations": [
                {
                    "end": 28,
                    "normalized_text": "asthma",
                    "probability": 0.4005,
                    "start": 23,
                    "type": "Other"
                },
                {
                    "end": 52,
                    "normalized_text": "SABA",
                    "probability": 0.3517,
                    "start": 49,
                    "type": "Other"
                },
                {
                    "end": 80,
                    "normalized_text": "SABA",
                    "probability": 0.3476,
                    "start": 77,
                    "type": "Place"
                }
            ],
            "hashtags": [
                {
                    "end": 29,
                    "start": 22,
                    "tag": "asthma"
                }
            ],
            "urls": [
                {
                    "display_url": "know.az/3ZrQAQR",
                    "end": 259,
                    "expanded_url": "https://know.az/3ZrQAQR",
                    "start": 236,
                    "status": 200,
                    "unwound_url": "https://www.astrazeneca.com/media-centre/articles/2021/countering-the-counter-productive-its-time-for-an-alternative-to-saba-only-asthma-treatment.html?utm_source=twitter&utm_medium=us+unbranded+-+asthma+social+campaign+2022&utm_term=11753&utm_content=r6i&linkId=196823309",
                    "url": "https://t.co/ZEhrvWeIqG"
                },
                {
                    "display_url": "pic.twitter.com/h382DJ2EAp",
                    "end": 283,
                    "expanded_url": "https://twitter.com/AstraZeneca/status/1613204147683172352/video/1",
                    "media_key": "13_1613204092658061315",
                    "start": 260,
                    "url": "https://t.co/h382DJ2EAp"
                }
            ]
        },
        "id": "1613204147683172352",
        "lang": "en",
        "public_metrics": {
            "bookmark_count": 1,
            "impression_count": 5667,
            "like_count": 15,
            "quote_count": 0,
            "reply_count": 11,
            "retweet_count": 4
        },
        "text": "Patients experiencing #asthma symptoms often use SABA inhalers. Yet taking a SABA does not address the underlying inflammation and may put patients at risk of future attacks. We're committed to helping to improve outcomes for patients. https://t.co/ZEhrvWeIqG https://t.co/h382DJ2EAp"
    }
}